Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients

An increased risk of posttransplant malignancy has been consistently reported following various solid organ transplants. The malignancies most commonly encountered are non-melanoma skin cancers, carcinomas of lung or breast and posttransplant lymphoproliferative disorders. Angiosarcoma, an uncommon...

Full description

Saved in:
Bibliographic Details
Published inClinical sarcoma research Vol. 4; no. 1; p. 15
Main Authors Baer, Lea N, Savage, David G, Hibshoosh, Hanina H, Kalinsky, Kevin
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 31.10.2014
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An increased risk of posttransplant malignancy has been consistently reported following various solid organ transplants. The malignancies most commonly encountered are non-melanoma skin cancers, carcinomas of lung or breast and posttransplant lymphoproliferative disorders. Angiosarcoma, an uncommon vascular mesenchymal neoplasm, is rare in the posttransplant setting. This report describes two patients who developed high-grade angiosarcoma following a solid organ transplant. Notably, in both patients, the diagnosis of angiosarcoma was preceded by diagnosis of a lymphoproliferative disorder with monoclonal immunoglobulin heavy chain rearrangement.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-3329
2045-3329
DOI:10.1186/2045-3329-4-15